Published in Proc Eur Dial Transplant Assoc on January 01, 1973
[Intensive vitamin D supplementation in the treatment of osteoporosis]. Vnitr Lek (2004) 1.41
Smoke cardiomyopathy: disturbance of oxidative processes in myocardial mitochondria. Cardiovasc Res (1984) 1.11
Hepatoprotective effect of rooibos tea (Aspalathus linearis) on CCl4-induced liver damage in rats. Physiol Res (2003) 0.94
The incidence of tumours in renal transplant recipients with long-term immunosuppressive therapy. Int Urol Nephrol (1999) 0.90
Insulin resistance and vitamin D deficiency in patients with chronic kidney disease stage 2-3. Physiol Res (2010) 0.84
Acute effect of hydrochlorothiazide on renal calcium and magnesium handling in postmenopausal women. Physiol Res (1999) 0.82
Inhibitor(s) of protein synthesis in uremic serum and urine: partial purification and relationship to amino acid transport. Biochem Med (1982) 0.82
Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension. J Cardiovasc Pharmacol (1994) 0.82
Hippurate participation in the inhibition of glucose utilization in renal failure. Czech Med (1987) 0.81
Carbohydrate metabolism by rat liver slices incubated in serum obtained from uraemic patients. Clin Sci (1969) 0.81
Influence of beta-resorcylidene aminoguanidine on selected metabolic parameters and antioxidant status of rats with diabetes mellitus. Physiol Res (2002) 0.81
Blood pressure, 5-OH indoleacetic acid, and vanilmandelic acid excretion and blood platelet aggregation in hypertensive patients treated with ketanserin. J Cardiovasc Pharmacol (1985) 0.80
Analytical identity of an inhibitor of sodium transport isolated from human serum and urine. Nephron (1985) 0.80
Effects of atorvastatin on heart mitochondrial function and coenzyme Q content in the experiment. Bratisl Lek Listy (2011) 0.80
Determination of apigenin in rat plasma by high-performance liquid chromatography. J Chromatogr A (2000) 0.80
Participation of P-dependent and P-independent glutaminases in rat kidney ammoniagenesis and their modulation by metabolic acidosis, hippurate and insulin. Physiol Res (1998) 0.80
DNA damage of lymphocytes in experimental chronic renal failure: beneficial effects of losartan. Kidney Int Suppl (2001) 0.80
Regeneration of coenzyme Q9 redox state and inhibition of oxidative stress by Rooibos tea (Aspalathus linearis) administration in carbon tetrachloride liver damage. Physiol Res (2004) 0.80
Serum hippurate and its excretion in conservatively treated and dialysed patients with chronic renal failure. Physiol Res (1991) 0.80
Rooibos tea (Aspalathus linearis) partially prevents oxidative stress in streptozotocin-induced diabetic rats. Physiol Res (2005) 0.80
Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products. J Hum Hypertens (2003) 0.79
Effect of hippurate on glucose utilization in rat kidney cortex slices. Ren Physiol Biochem (1991) 0.79
Gluconeogenesis in rat kidney after partial hepatectomy. Physiol Bohemoslov (1971) 0.79
Oxidative stress and plasma concentrations of coenzyme Q10, alpha-tocopherol, and beta-carotene in patients with a mild to moderate decrease of kidney function. Nephron (2001) 0.79
Does magnesium dysbalance participate in the development of insulin resistance in early stages of renal disease? Physiol Res (2002) 0.78
Advanced glycation end-product levels in subtotally nephrectomized rats: beneficial effects of angiotensin II receptor 1 antagonist losartan. Miner Electrolyte Metab (2000) 0.78
A highly sensitive HPLC method for the simultaneous determination of acetylsalicylic, salicylic and salicyluric acids in biologic fluids: pharmacokinetic, metabolic and monitoring implications. Methods Find Exp Clin Pharmacol (1996) 0.78
[Vitamin D: synthesis, metabolism, regulation, and an assessment of its deficiency in patients with chronic renal disease]. Vnitr Lek (2004) 0.77
Metabolic alterations caused by uraemia. Proc Eur Dial Transplant Assoc (1980) 0.77
A procedure for the isolation of an inhibitor of sodium transport from the urine of uraemic patients. Physiol Bohemoslov (1982) 0.77
Relation between the uptake of glucose and fatty acids by the rat kidney in vivo. Physiol Bohemoslov (1972) 0.77
[Effect of losartan on antioxidant status in rats with diabetes mellitus]. Ceska Slov Farm (2001) 0.77
Magnesium deficiency impairs rat soleus muscle glucose utilization and insulin sensitivity. Mater Med Pol (1993) 0.76
Metabolism of palmitate-1-14C in the tissues of rats with streptozotocin diabetes. Physiol Bohemoslov (1981) 0.76
Fibrates and renal function. Clin Nephrol (2003) 0.76
Enalapril in subantihypertensive dosage attenuates kidney proliferation and functional recovery in normotensive ablation nephropathy of the rat. Physiol Res (1999) 0.76
Does rooibos tea (Aspalathus linearis) support regeneration of rat liver after intoxication by carbon tetrachloride? Gen Physiol Biophys (2008) 0.76
[Effect of coenzyme Q10 in patients with kidney diseases]. Cas Lek Cesk (2001) 0.75
Accumulated end products participate in glucose intolerance and insulin resistance in uremia. Nephron (1993) 0.75
[Inhibition of red blood cell glucose utilization in uremia]. Vnitr Lek (1974) 0.75
Release of free fatty acids by the rat kidney. Physiol Bohemoslov (1977) 0.75
Pathophysiology of the carbohydrate metabolism in renal insufficiency. Rev Czech Med (1974) 0.75
[70th birthday of Prof. Jaroslav Horejsí, M.D., D.Sc., Member Correspondent of the Czechoslovak Academy of Sciences]. Bratisl Lek Listy (1975) 0.75
The synthesis of middle molecular substances in rat tissues: in vitro study. Proc Eur Dial Transplant Assoc (1978) 0.75
[Clinicopharmacologic aspects of the effects of serotonin and its blockade]. Bratisl Lek Listy (1985) 0.75
Inhibition of glucose utilization in rat diaphragm by the urinary peptides fractionated by high-voltage electrophoresis. Int Urol Nephrol (1973) 0.75
[Modern diagnosis of energy and nitrogen balance in renal insufficiency]. Bratisl Lek Listy (1984) 0.75
Ninhydrin-positive substances in serum and urine of patients with chronic uraemia. Clin Chim Acta (1972) 0.75
[Use of ethacrynic acid in the teatment of edematous states]. Bratisl Lek Listy (1973) 0.75
[Choice of amoxycilin dosage in impaired renal function (author's transl)]. Bratisl Lek Listy (1978) 0.75
[Clinical investigation of the sulfonamide diuretic, azosemide (BM 02 001)]. Vnitr Lek (1979) 0.75
[Prevention of chronic pyelonephritis relapses using metenamine hipuran (author's transl)]. Cas Lek Cesk (1979) 0.75
[Uptake and utilization of palmitate 1 14C by some rat tissues in a medium of diabetic serum (author's transl)]. Cesk Gastroenterol Vyz (1978) 0.75
[Repeated administration of furosemide in intensive treatment of edema]. Vnitr Lek (1976) 0.75
[Rational indications for clinico-biochemical studies]. Cas Lek Cesk (1983) 0.75
Effect of glucose utilization inhibitor isolated from the serum and urine of patients with chronic renal failure on the free fatty acid metabolism in rat kidney cortex slices. Physiol Bohemoslov (1976) 0.75
[Short-term dialyses using a conventional hemodialyzer]. Z Urol Nephrol (1978) 0.75
[Treatment of schizophrenia using hemodialysis]. Cesk Psychiatr (1985) 0.75
[Evaluation of education of health service laboratory technicians]. Zdrav Prac (1970) 0.75
Abnormal carbohydrate metabolism in patients with liver cirrhosis; in vitro study. Diabetologia (1972) 0.75
Erythrocyte glycolysis in uraemia: cynamic balance caused by the opposite action of various factors. Int Urol Nephrol (1974) 0.75
Abnormal carbohydrate metabolism in uraemia. Some properties of the inhibitor of glucose utilization present in the serum of uraemic patients. Int Urol Nephrol (1971) 0.75
[Ketanserin in the treatment of ischemic disease of the lower extremities]. Cas Lek Cesk (1985) 0.75
[Cefalotin SPOFA in the treatment of urinary infections]. Bratisl Lek Listy (1983) 0.75
[Importance of spironolactone in the diuretic treatment]. Vnitr Lek (1974) 0.75
[Acute antihypertensive and diuretic effects of Metipamide VUFB]. Vnitr Lek (1985) 0.75
[Effect of fasting on the free fatty acid metabolism in sections of the kidney cortex of rats (author's transl)]. Cesk Gastroenterol Vyz (1976) 0.75
[Serotonin antagonists in the treatment of hypertension]. Cas Lek Cesk (1984) 0.75
[Combination of methyldopa and diuretics in the treatment of hypertensive disease]. Vnitr Lek (1985) 0.75
Liver glycogen concentration in patients with chronic uremia. Experientia (1968) 0.75
Influence of inhibitor of glucose utilization on the blood platelet function. Nephron (1983) 0.75
[Metabolic changes in chronic kidney failure]. Bratisl Lek Listy (1978) 0.75
[Use of amiloride in diuretic treatment (author's transl)]. Bratisl Lek Listy (1975) 0.75
Middle molecular substances in acute renal failure. Int Urol Nephrol (1982) 0.75
[The effect of hemoperfusion through activated charcoal on middle molecular substances in the plasma during a long-term dialysis program]. Cas Lek Cesk (1983) 0.75
[Treatment of oedematous conditions in combining amilorid and hydrochlorothiazid (author's transl)]. Bratisl Lek Listy (1976) 0.75
[Metabolic changes in renal insufficiency]. Z Gesamte Inn Med (1978) 0.75
Carbohydrate metabolism in renal medullary slices. Physiol Bohemoslov (1967) 0.75
Glucose utilization in muscle during uremia; in vitro study. Clin Chim Acta (1970) 0.75
[Nutritional status of patients before kidney transplantation]. Vnitr Lek (1984) 0.75
[How long and how often to dialyse patients with chronic renal failure (author's transl)]. Cas Lek Cesk (1977) 0.75
Effect of glucose on the utilization of palmitate 1 14C by rat kidney cortex slices. Physiol Bohemoslov (1975) 0.75
[Uremia and glycide metabolism]. Cesk Fysiol (1973) 0.75
Plasma middle molecular substances (MMS) in schizophrenic patients. Int J Artif Organs (1979) 0.75
[Dihydralazin treatment of hypertension during hemodialysis]. Z Urol Nephrol (1973) 0.75
[Nephrotoxic effects of gentamicin in patients with damaged kidneys (author's transl)]. Bratisl Lek Listy (1979) 0.75
Acute effects of antagonist of S2-receptors. Czech Med (1984) 0.75
Relationship between free fatty acids and glucose uptake by rat kidney cortex slices. Physiol Bohemoslov (1972) 0.75
Pathogenesis of metabolic alterations in renal failure. Czech Med (1984) 0.75
Localization of the inhibition of gluconegenesis in kidney slices by uremic serum. Med Exp Int J Exp Med (1968) 0.75
[Can the concentration of middle molecular substances in plasma contribute to the assessment of the adequacy of regular dialysis therapy?]. Cas Lek Cesk (1984) 0.75
[Diuretic effects of chlorthalidone]. Vnitr Lek (1979) 0.75
[Cephalotin therapy in renal insufficiency (author's transl)]. Cas Lek Cesk (1976) 0.75
Effect of vitamin D on serum calcium and inorganic phosphorus concentration in intermittently haemodialyzed patients. Int Urol Nephrol (1972) 0.75
[Use of lactate in chronic uremia]. Vnitr Lek (1969) 0.75
[Potential nephrotoxicity of amoxicillin in patients with reduced renal function (author's transl)]. Bratisl Lek Listy (1980) 0.75
[Mean molecular substance volume in the sera of patients after kidney transplant operation (author's transl)]. Cas Lek Cesk (1977) 0.75
Serum and ultradiafiltrate middle molecules in hemodialysed patients. Int Urol Nephrol (1979) 0.75
[Effect of the inhibitor of glucose utilization, isolated from serum of patients in uremia, upon morphology and membrane permeability of erythrocytes (author's transl)]. Bratisl Lek Listy (1974) 0.75
Effect of vitamin D on serum magnesium concentration in intermittently haemodialyzed patients. Int Urol Nephrol (1972) 0.75